Medications causing vision loss: Difference between revisions
From IDWiki
(Imported from text file) |
No edit summary |
||
| Line 1: | Line 1: | ||
| + | {| class="wikitable" |
||
| ⚫ | |||
| + | !Medication |
||
| − | * Bisphosphonates: uveitis |
||
| + | !Details |
||
| − | * Digoxin: yellow vision |
||
| + | |- |
||
| − | * Rifabutin: uveitis |
||
| + | |[[anticholinergics]] |
||
| − | * Sildenafil: blue vision, ischemic optic neuropathy |
||
| ⚫ | |||
| − | * Sulfonamides: myopia |
||
| + | |- |
||
| ⚫ | |||
| + | |[[bisphosphonates]] |
||
| ⚫ | |||
| + | |[[uveitis]] |
||
| ⚫ | |||
| + | |- |
||
| − | * Avariety of cancer therapy drugs (biologics, small molecule inhibitors chemotherapies): retinopathy, uveitis, acute dry eye |
||
| + | |[[digoxin]] |
||
| − | |||
| + | |yellow-tinted colour vision |
||
| + | |- |
||
| + | |[[rifabutin]] |
||
| + | |[[uveitis]] |
||
| + | |- |
||
| + | |[[sildenafil]] |
||
| + | |blue-tinted colour vision, ischemic optic neuritis |
||
| + | |- |
||
| + | |[[sulfonamides]] |
||
| + | |[[myopia]] |
||
| + | |- |
||
| + | |[[topiramate]] |
||
| ⚫ | |||
| + | |- |
||
| + | |[[oral contraceptives]] |
||
| ⚫ | |||
| + | |- |
||
| + | |[[fingolimod]] |
||
| ⚫ | |||
| + | |- |
||
| + | |chemotherapy and biologics |
||
| + | |[[retinopathy]], [[uveitis]], acute dry eye |
||
| + | |} |
||
| + | <br /> |
||
[[Category:Neurology]] |
[[Category:Neurology]] |
||
[[Category:Ophthalmology]] |
[[Category:Ophthalmology]] |
||
Latest revision as of 12:27, 14 November 2020
| Medication | Details |
|---|---|
| anticholinergics | loss of accommodation, angle closure glaucoma |
| bisphosphonates | uveitis |
| digoxin | yellow-tinted colour vision |
| rifabutin | uveitis |
| sildenafil | blue-tinted colour vision, ischemic optic neuritis |
| sulfonamides | myopia |
| topiramate | angle closure glaucoma |
| oral contraceptives | ischemic, retinal, or optic nerve events |
| fingolimod | macular edema |
| chemotherapy and biologics | retinopathy, uveitis, acute dry eye |
